(Q41503315)

English

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality

scientific article published on 30 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Christopher D Byrne

4

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

author name string

Ki-Chul Sung

1

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Sarah H Wild

3

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

language of work or name

0 references

publication date

30 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

553-558

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

The Year in Cardiology 2013: cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Metabolic and functional relevance of HDL subspecies

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

High-density lipoprotein heterogeneity and function in reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Cardioprotective functions of HDLs

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Anti-inflammatory functions of apolipoprotein A-I and high-density lipoprotein are preserved in trimeric apolipoprotein A-I.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

HDL cholesterol: all hope is not lost after the torcetrapib setback--emerging therapeutic strategies on the horizon

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2014-306784

21 January 2018

Identifiers

10.1136/HEARTJNL-2014-306784

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41503315&oldid=2143021079"